Bosch rejects diesel allegations as ‘wild and unfounded’
(Reuters) – Auto supplier Robert Bosch GmbH said claims it was a knowing participant in Volkswagen’s decade-long scheme to evade U.S. anti-pollution laws were “wild and unfounded.”
Global stocks creep up amid Fed limbo, dollar dips
LONDON (Reuters) – World shares crept up on Tuesday while the dollar lost ground as investors awaited further clues on whether the Federal Reserve will raise U.S. interest rates this year.
Waldorf Astoria owner Anbang plans Hong Kong IPO of life insurance unit: sources
HONG KONG (Reuters) – Anbang Insurance Group Co, which owns New York’s Waldorf Astoria hotel, plans to list its life insurance business in Hong Kong and has invited investment banks to pitch for advisory mandates in the coming weeks, sources familiar w…
Cobalt International says Angola oil block stake sale terminated
(Reuters) – Cobalt International Energy Inc said the proposed $1.75 billion sale of a 40 percent stake in two offshore oil blocks in Angola to the state oil company was terminated as it did not get the necessary approvals from the country’s government…
Toll Brothers revenue beats estimates on higher home sales
(Reuters) – Toll Brothers Inc reported a rise in revenue for the fourth straight quarter, beating analysts’ estimates, as it sold more luxury homes at higher prices, suggesting a steady growth in the U.S. housing market.
U.S. clearance of ChemChina’s Syngenta deal removes key hurdle
(Reuters) – A U.S. national security panel has cleared ChemChina’s $43 billion takeover of Swiss pesticides and seeds group Syngenta , the companies said, boosting chances that the largest foreign acquisition ever by a Chinese company will go through.
Pfizer boosts cancer drug roster with $14 billion Medivation deal
(Reuters) – Pfizer Inc , beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster.
Wall St. little changed as biotechs offset energy drop
(Reuters) – U.S. stocks were little changed on Monday as a drop in oil prices that weighed on the energy sector was offset with a strong showing by biotech stocks.
U.S. banks want to cut branches, but customers keep coming
NEW YORK (Reuters) – Despite banks’ nudging toward online tools, many U.S. customers are not ready to give up regular visits to their nearest branch, complicating the industry’s efforts to slim down.
Federal Reserve under growing pressure to reform system, goals
WASHINGTON (Reuters) – The U.S. Federal Reserve has two guiding goals when designing monetary policy: maximum employment and stable inflation.
